| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 600736 | 68103 | ARTICAINA / EPINEFRINA DERMOGEN 40 MG/ML + 10 MICROGRAMOS/ML SOLUCION INYECTABLE EFG | ARTICAINA / EPINEFRINA DERMOGEN 40 MG/ML + 10 MICROGRAMOS/ML SOLUCION INYECTABLE EFG , 100 cartuchos de 1,8 ml | 40 mg/ml + 10 microgramos/ml inyectable 1,8 ml | 1 | 100 | 57 | 100 cartuchos de 1,8 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68103/68103_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68103/68103_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 20366 | 20366 | 2006-10-24 | 1 | 1 | 1 | 2014-12-09 | 2014-12-09 | 1 | 2017-11-07 | View Edit Delete | ||||||||||||
| 600737 | 68104 | ARTICAINA / EPINEFRINA DERMOGEN 40 MG/ML + 5 MICROGRAMOS/ML SOLUCION INYECTABLE EFG | ARTICAINA / EPINEFRINA DERMOGEN 40 MG/ML + 5 MICROGRAMOS/ML SOLUCION INYECTABLE EFG , 100 cartuchos de 1,8 ml | 40 mg/ml + 5 microgramos/ml inyectable 1,8 ml | 1 | 100 | 57 | 100 cartuchos de 1,8 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68104/68104_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68104/68104_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 20366 | 20366 | 2006-10-24 | 1 | 1 | 1 | 2014-12-09 | 2014-12-09 | 1 | 2017-11-07 | View Edit Delete | ||||||||||||
| 659270 | 68934 | CALCITRIOL KERN PHARMA 1 microgramo/ml SOLUCION INYECTABLE EFG | CALCITRIOL KERN PHARMA 1 microgramo/ml SOLUCION INYECTABLE EFG, 25 ampollas de 1 ml | 1 microgramo | 1 | 25 | 1 | 25 ampollas de 1 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68934/68934_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68934/68934_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1534 | 1534 | 2007-06-11 | 1 | 1 | 1 | 2007-06-11 | 2007-06-11 | 1 | 2011-10-17 | View Edit Delete | ||||||||||||
| 732485 | 1211594001 | RYBREVANT 350 MG CONCENTRADO PARA SOLUCION PARA PERFUSION | RYBREVANT 350 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 7 ml | 350 mg inyectable 7 ml | 45 | 1 | 34 | 1 vial de 7 ml | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1211594001/1211594001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211594001/1211594001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 6153 | 71027 | 2022-01-12 | 1 | 1 | 1 | 2022-01-13 | 2022-01-12 | 1 | 2025-11-12 | View Edit Delete | ||||||||||||
| 765251 | 1241823004 | WEZENLA 130 MG CONCENTRADO PARA SOLUCION PARA PERFUSION | WEZENLA 130 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 26 ml | 130 mg inyectable 26 ml | 45 | 1 | 34 | 1 vial de 26 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241823004/1241823004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241823004/1241823004_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 24978 | 41943 | 2024-06-26 | 1 | 1 | 1 | 2024-06-27 | 2024-06-26 | 1 | 2024-08-09 | View Edit Delete | ||||||||||||
| 765713 | 1241844003 | STEQEYMA 130 MG CONCENTRADO PARA SOLUCION PARA PERFUSION | STEQEYMA 130 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 26 ml | 130 mg inyectable 26 ml | 45 | 1 | 34 | 1 vial de 26 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241844003/1241844003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241844003/1241844003_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 32858 | 1534 | 2024-09-11 | 1 | 1 | 1 | 2024-09-12 | 2024-09-11 | 1 | 2024-10-15 | View Edit Delete | ||||||||||||
| 765861 | 1241863003 | OTULFI 130 MG CONCENTRADO PARA SOLUCION PARA PERFUSION | OTULFI 130 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 26 ml | 130 mg inyectable 26 ml | 45 | 1 | 34 | 1 vial de 26 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241863003/1241863003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241863003/1241863003_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1097 | 14285 | 2024-09-30 | 1 | 1 | 1 | 2024-10-01 | 2024-09-30 | 1 | 2025-02-11 | View Edit Delete | ||||||||||||
| 768395 | 1251957004 | USYMRO 130 MG CONCENTRADO PARA SOLUCION PARA PERFUSION | USYMRO 130 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 26 ml | 130 mg inyectable 26 ml | 45 | 1 | 34 | 1 vial de 26 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1251957004/1251957004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1251957004/1251957004_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 8334 | 10616 | 2025-09-01 | 1 | 1 | 1 | 2025-09-02 | 2025-09-01 | 1 | 2025-10-30 | View Edit Delete |